Form 4: Director William Feehery Acquires WST Restricted Stock

Director William F. Feehery acquired 791 restricted stock units of West Pharmaceutical Services, Inc. as part of director compensation.

Summary

• Director William F. Feehery was granted 791 restricted stock units (RSUs) of West Pharmaceutical Services, Inc. (WST).
• The transaction occurred on May 4, 2026.
• The shares were acquired at a price of $0, representing equity-based compensation.
• Following this transaction, the director's total beneficial ownership is 32,519.345 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial outlook.

Positives

• Alignment of director interests with shareholders through equity-based compensation.
• Increase in total beneficial ownership by a member of the board.

Negatives

• None identified.

Risks

• None identified.

Future Outlook

The restricted stock units are scheduled to vest in full on the date of the next annual shareholder meeting and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are standard corporate governance practice to ensure long-term alignment with shareholder value in the pharmaceutical packaging and delivery systems sector.

Comparison to Industry Standards

• The grant of restricted stock units to directors is consistent with standard compensation practices for S&P 500 and mid-cap healthcare companies.
• The vesting schedule tied to the annual shareholder meeting is a common practice for board members to ensure retention through the annual cycle.

Corporate Governance

Stakeholder Impact

• Shareholders: Minimal impact; reflects standard director compensation structure.

Next Steps

• Vesting of the 791 restricted stock units upon the next annual shareholder meeting.

Key Dates

Keywords

WST, West Pharmaceutical Services, Form 4, Insider Trading, Director Compensation, Equity Grant